Skip to content
Powering the UK's most efficient NHS Right to Choose providers
← Blog

How big is the private self-pay market for ADHD and autism assessments in England?

Patients in England pay an estimated £51m to £157m a year for their own ADHD and autism assessments. How we sized it, and the share who pay that decides it.

Dr. Moniem Abdu · Co-Founder & CEO, Cerebric· · 10 min readIllustrative estimate
Cerebric LogoCerebric
Market
In this article
  1. 1. How we sized it: the driver tree
  2. 2. The four inputs
  3. 3. The results: £51m to £157m a year
  4. 4. One-off sums: people already waiting and undiagnosed adults
  5. 5. Paying privately is rising
  6. 6. What the estimate leaves out
  7. About the author
  8. Citations

Patients in England pay an estimated £51m to £157m a year for their own ADHD and autism assessments, with a midpoint of about £90m. The range is wide because it depends most on the share of people who pay. It comes down to five points:

  1. Patients who pay each year come by two routes: through an NHS waiting list first, or straight to private.
  2. The estimate rests on four inputs: we have data for two (NHS referrals and prices), and two are assumptions based on surveys (the share who pay and the share who go straight to private).
  3. About 35,000 to 113,000 people pay each year, worth an estimated £51m to £157m, out of about 547,000 who seek an assessment.
  4. People already on NHS waiting lists could be worth a one-off £66m to £200m on top of the yearly market, and adults with undiagnosed ADHD £18m to £193m, but each would be paid only once.
  5. Private healthcare use has nearly doubled since 2023, and more people go straight to private as NHS waiting lists grow.

How we built this. The driver tree in section 1 shows every input and how they combine. Each input has a source next to it. The share who pay comes from surveys of all private healthcare, shown as a range, and the calculator in section 3 lets you change it, the share going straight to private and the price.

1. Patients who pay each year come by two routes: through an NHS waiting list first, or straight to private#

Driver tree: how we size the yearly self-pay market, starting from NHS referralsEach box is calculated from the boxes to its right. The rest of the article refers to the boxes by letter.Calculated from the boxes to its rightData: NHS figures or published pricesAssumption from surveys of private healthcareNo dataYearly self-pay marketAPatients who pay in a yearBEveryone seeking an assessment in a yearCNHS referrals in a year+DPatients who go straight to private (IHPN benchmark: 44% of A)×EShare who pay×FPrice per assessmentA splits by route, using IHPN's benchmark: 56% join an NHS waiting list first and then pay; 44% go straight to private D.Not used: B could also be built as the population × the share with ADHD or autism × the share who seek help in a year, but no survey measures the share who seek help in a year.

Why we start from NHS referrals
  • Ideally, B would be the population × the share with ADHD or autism × the share who seek help in a year.
  • No survey measures the share who seek help in a year, so we build B from the data available: NHS referrals and IHPN's benchmark.
  • A survey asking who sought an assessment in the past year, and by which route, would size the market more directly.

Why this is a yearly figure, not a one-off total:

  • Leaving out the share who seek help in a year gives a one-off total instead: what everyone with ADHD or autism might ever pay.
  • That money is paid only once, so it can't be added to the yearly market. Services we speak to often skip this step, which makes the market look larger than the revenue available each year.
  • Section 4 sizes two of these one-off totals.

2. The estimate rests on four inputs: we have data for two, and two are assumptions based on surveys#

InputValueSource
C. NHS referrals (data)520,000 a year: adults 315,000, children 205,000NHS England, 12 months to June 2026 (ADHD; autism)
E. Share who pay (assumption from surveys)Adults 5% to 19% (midpoint 9%); children 9% to 21% (midpoint 15%, halfway between)Adults: Healthwatch England × YouGov; children: Sutton Trust
F. Price (data)£995 adult ADHD, £1,250 child ADHD, £1,850 adult autism, £2,050 child autismADHD Private; 13 providers' published autism fees, October 2026
Share who go straight to private (assumption from a survey)44% of people who used private healthcare. D, the number of patients, is 44% × AIHPN
  • NHS referrals: the ADHD count is an upper bound: it includes referrals that may be for ADHD, and anyone referred for both ADHD and autism is counted twice.
  • Share who pay: the surveys count everyone who paid, whichever route they took, so the share applies to everyone seeking an assessment, not only to NHS referrals.
  • The 44% share covers all UK private healthcare, including GP appointments.

3. About 35,000 to 113,000 people pay each year, worth an estimated £51m to £157m#

Each type of assessment is worked out the same way, and the four add up to the total:

Illustrative estimateThe yearly self-pay market is about £51m to £157m, depending most on the share who payEach block is one type of assessment: its width is the number of people who want that assessment a year, and the amber band is the share who pay. Move the three assumptions under the chart to see how the market changes.Adult ADHD237k people21k pay (9%)£21mAdult autism90k people8k pay (9%)£15mChild ADHD116k people17k pay (15%)£22mChild autism103k people16k pay (15%)£32mPay for their assessmentDon't payAdult: 9%Child: 15%44%Adult: ADHD £995, autism £1,850Child: ADHD £1,250, autism £2,050With these settings, about 547k people seek an assessment a year and about 62k of them pay, worth about £90m a year: £50m from patients who joined an NHS waiting list first and £40m from patients who went straight to private.Limitations• The share who pay comes from surveys of all adults and all private healthcare, not people seeking an ADHD or autism assessment.• The 44% going straight to private covers all UK private healthcare, including private GP visits.• Assessments paid for by insurers or employers aren't included; insurers mostly cover them only as an add-on that employers buy.• Assessments only: titration, follow-ups and prescriptions are extra.

At the midpoint:

  • About 547,000 people seek an assessment a year (B): 520,000 NHS referrals (C) plus about 27,000 who go straight to private (D).
  • About 62,000 of them pay (A): 35,000 after joining an NHS waiting list and 27,000 straight to private.
  • About 7% of NHS referrals go on to pay privately, or 4% to 12% across the range. This follows from the 44% benchmark: the 56% of A who join a waiting list first, divided by NHS referrals.

How much each assumption matters:

  • The share who pay matters most. From the lower to the upper estimate, the market runs from about £51m to £157m. Cost holds many people back: of people waiting for an ADHD assessment who weren't considering going private, 61% said they couldn't afford it (Healthwatch England, 2025).
  • Price matters next. If private prices fell to NHS guide prices (£860 adult ADHD, £1,163 adult autism), the midpoint would drop from about £90m to about £66m.
  • The 44% going straight to private barely matters. Anywhere from 25% to 55% gives £88m to £91m, because it mostly changes how the market splits between the two routes.
Show our working

Why A is worked out this way: D is 44% of A, so A appears on both sides of the equation. Solving for A gives the second line:

A Patients who pay = E share who pay × (C NHS referrals + D 44% of A)SolvedA = E × C ÷ (1 − 44% × E)

It is worked out separately for adults and children, because their share who pay differs, and for ADHD and autism, because their prices differ. The results are then added up.

Calculated (midpoint, with the range in brackets)

BoxValueHow
A. Patients who pay62,000 (35,000 to 113,000)E × C ÷ (1 − 44% × E)
D. Patients who go straight to private27,000 (16,000 to 50,000)44% × A
B. Everyone seeking an assessment547,000 (535,000 to 569,000)C + D

Output

ValueHow
Yearly self-pay market£90m (£51m to £157m)A × F

Illustrative estimateAt the midpoint, about 62,000 patients pay about £90m a yearThe driver tree with the midpoint figure in each box. Adults and children, and ADHD and autism, are worked out separately and then added up.Calculated from the boxes to its rightData: NHS figures or published pricesAssumption from surveys of private healthcareYearly self-pay market£90mAPatients who pay in a year62,000BEveryone seeking an assessment in a year547,000CNHS referrals in a year520,000+DPatients who go straight to private (IHPN benchmark: 44% of A)27,000×EShare who payAdults 9%, children 15%×FPrice per assessment£995 to £2,050, by type

4. People already on NHS waiting lists could be worth a one-off £66m to £200m, on top of the yearly market#

Two groups would each pay only once, so neither can be added to the yearly market:

  • People already on NHS waiting lists: about £66m to £200m. About 1.25 million people were waiting in June 2026, and about 4% to 12% of them could go on to pay.
  • Adults with undiagnosed ADHD: about £18m to £193m. An estimated 366,000 to 1,020,000 adults have ADHD without a diagnosis.

The two overlap, so they can't be added together either.

The waiting list may already hold the majority of these adults:

  • About 573,000 adults were waiting for an NHS ADHD assessment in June 2026, more than half of the undiagnosed adults.
  • The comparison is rough: the survey dates from 2023/4, the waiting list counts referrals rather than people, and not everyone on it has ADHD.
  • There is no current estimate of how many adults are autistic, so autistic adults can't be sized this way.
Show our working

Both use the same tree with a different starting number in place of B:

People waitingOne-off total = people waiting × share of NHS referrals who pay × F priceUndiagnosedOne-off total = undiagnosed adults × E share who pay × £995 price

People already waiting:

  • About 1.25 million people were on ADHD and autism waiting lists in June 2026 (NHS England ADHD Management Information; NHS England Autism Statistics).
  • They have already taken the NHS route, so the ringed share is the share of NHS referrals who go on to pay: about 4% to 12%.
  • The ADHD figure for children includes 179,232 people on community paediatrics lists, which NHS England counts for ages 5 to 24, so some are young adults.

Adults with undiagnosed ADHD:

  • Adults expected to have ADHD: 1,210,000 to 1,864,000. The lower end is 2.58% of England's 46.9 million adults aged 18 and over (John, Stewart et al., from Song et al.; ONS); the upper end is NHS England's estimate of adults with ADHD (NHS England).
  • Adults who report a diagnosis: 1.8% of adults aged 16 and over, applied to the 46.9 million aged 18 and over (Adult Psychiatric Morbidity Survey 2023/4).
Undiagnosed adults = expected to have ADHD − with a diagnosisRange366,000 to 1,020,000 = 1,210,000 to 1,864,000 − 844,000

5. Private healthcare use has nearly doubled since 2023, and more people go straight to private#

  • Private healthcare use, the basis of the share who pay (E), rose from 9% of adults in 2023 to 16% in 2025 (two Healthwatch England polls; Healthwatch England).
  • The share of people using private healthcare who went straight to private, the basis of D, rose from 40% to 44% in a year (IHPN).
  • 38% of people waiting for an ADHD assessment were considering paying privately, and 65% of them gave the wait as the main reason (Healthwatch England, 2025).
  • The recorded ADHD waiting list grew by 39% in the year to June 2026 (NHS England ADHD Management Information).

6. The estimate leaves out insurer-paid assessments and the rest of the UK#

  • Assessments paid for by insurers. No one publishes a national count.
    • Standard individual cover usually excludes ADHD and autism; insurers pay mainly through add-on benefits that employers buy.
    • The only published insurer figures, from AXA Health (AXA Health) and Aviva (COVER), cover 2023/24 (Aviva) and 2025 (AXA).
  • The rest of the UK. The estimate covers England only, because the NHS referral data it starts from is for England.
    • England has about 85% of the UK's population (ONS, mid-2025), so scaling up by population gives a rough UK figure of about £60m to £185m a year, with a midpoint of about £106m.
    • Treat that as a rough guide. Scotland, Wales and Northern Ireland run their own NHS systems, with their own waiting lists and no Right to Choose, so the share who pay, and the share who go straight to private, may differ from England's.

For how self-pay fits alongside NHS funding, prices and margins, see Is the ADHD and autism assessment market still economically viable in 2027?

About the author

Dr. Moniem Abdu headshot

Dr. Moniem Abdu

Founder & CEO, Cerebric

Dr. Moniem combines medical training with experience at McKinsey & Company's AI arm, QuantumBlack. His NHS experience revealed how poorly designed systems disrupt clinical focus, driving him to build clinician-first tools that reduce cognitive load and protect clinical judgement.

Profile and all articles
Citations(14)
  1. NHS England: ADHD Management Information (August 2026)
  2. NHS England: Autism Statistics, July 2025 to June 2026
  3. Independent Healthcare Providers Network: Going Private 2026
  4. Healthwatch England: ADHD report (May 2025)
  5. Healthwatch England: The state of health and social care in 2026 (March 2026)
  6. Sutton Trust: Double Disadvantage (October 2025)
  7. YouGov: One in seven Britons turned to private healthcare in the last 12 months
  8. ADHD Private: The UK Private ADHD Market in 2026
  9. NHS England: Adult Psychiatric Morbidity Survey 2023/4, ADHD
  10. John, Stewart et al.: Lancet Regional Health – Europe (2026)
  11. ONS: Population estimates for England and Wales, mid-2025
  12. ONS: Population estimates for the UK, England, Wales, Scotland and Northern Ireland, mid-2025
  13. AXA Health: Neurodiversity assessment service and onward care
  14. COVER: Aviva's neurodevelopmental pathway in its first year (August 2024)